Centers

Therapeutic Accelerator Program (TAP)

Chemical Genomics Facility at Purdue Institute for Drug Discovery

BLAVATNIK CENTER for Drug Discovery

Test

Read more
The Chemical Genomics Facility is a core facility at Purdue Institute for Drug Discovery that provides expertise and resources needed in the early stage of drug discovery. The services include small molecule libraries, access to automated equipment...
Read more
The BLAVATNIK CENTER for Drug Discovery (BCDD) is a fully integrated center for translational research, based at Tel Aviv University, that comprises medicinal chemistry, biological target identification and computer-assisted drug design units under...
Read more

Partnerships

Events

Jobs

Johns Hopkins BSi Licenses GCPII Assets from Eisai

Johns Hopkins Brain Science Institute ("BSi") has taken a non-exclusive license from Eisai to develop new compounds related to Glutamate Carboxypeptidase II (GCP-II) technology. The new compounds developed under this license will be targeted...

 
View all

Argenta and ANTABIO Announce Drug Discovery Collaboration

Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, announced today that it has achieved a milestone with its collaboration partner Antabio in an anti-bacterial drug...

 
View all

Roche to Collaborate with UCSD Scientists

Roche and UC San Diego have established UC San Diego-Roche Extending Innovation Network (EIN) program. The program aims to accelerate drug discovery development through joint collaboration and leveraging academic and industry expertise. Under this...

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All